Move Starts To Strip Anticancer Drug Regulation From FDA After New Charges It Is Delaying INDs
In Brief: NCI Needs To Move Quicker On Funding Jot New Leads, Rauscher Says; Harley Dirks Quits
Frederick RFP Held Up; NCI Probably Will Reject Any Further Delay
Moloney Convinces Most NCAB Members Of Virus Program Value, Shubik Only Dissenter
King Tells Centers To Concentrate On Project Grants
First Lady Helps Dedicate New MDA Facilities
Disease Oriented Programs Must Be Coordinated: Rabson
Trending Stories
- Franco Muggia, former head of CTEP and NYU cancer center, dies at 85
- ACOG says it will no longer accept federal funding
- Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group - Robert A. Winn on his new vision to train cancer center leaders: “I had a big bold idea and an ‘Aha!’ moment.”
- Gardiner Harris, acclaimed health care and pharma journalist, on his New York Times bestselling book
- Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills